An Almond-Based Low Carbohydrate Diet Improves Depression and Glycometabolism in Patients with Type 2 Diabetes through Modulating Gut Microbiota and GLP-1: A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Background: Alow carbohydrate diet (LCD) is more beneficial for the glycometabolism in type 2 diabetes (T2DM) and may be effective in reducing depression. Almond, which is a common nut, has been shown to effectively improve hyperglycemia and depression symptoms. This study aimed to determine the effect of an almond-based LCD (a-LCD) on depression and glycometabolism, as well as gut microbiota and fasting glucagon-like peptide 1 (GLP-1) in patients with T2DM. Methods: This was a randomized controlled trial which compared an a-LCD with a low-fat diet (LFD). Forty-five participants with T2DM at a diabetes club and the Endocrine Division of the First and Second Affiliated Hospital of Soochow University between December 2018 to December 2019 completed each dietary intervention for 3 months, including 22 in the a-LCD group and 23 in the LFD group. The indicators for depression and biochemical indicators including glycosylated hemoglobin (HbA1c), gut microbiota, and GLP-1 concentration were assessed at the baseline and third month and compared between the two groups. Results: A-LCD significantly improved depression and HbA1c (p < 0.01). Meanwhile, a-LCD significantly increased the short chain fatty acid (SCFAs)-producing bacteria Roseburia, Ruminococcus and Eubacterium. The GLP-1 concentration in the a-LCD group was higher than that in the LFD group (p < 0.05). Conclusions: A-LCD could exert a beneficial effect on depression and glycometabolism in patients with T2DM. We speculate that the role of a-LCD in improving depression in patients with T2DM may be associated with it stimulating the growth of SCFAs-producing bacteria, increasing SCFAs production and GPR43 activation, and further maintaining GLP-1 secretion. In future studies, the SCFAs and GPR43 activation should be further examined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283 · cited 1×
“around 415 million people with diabetes worldwide, a figure likely to increase to 629 million by 2045 [1].”
BackgroundThe Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926 · cited 1×
“Furthermore, epidemiological evidence indicated that patients with T2DM are almost three times as likely to be affected by depression compared with the general population [4].”
BackgroundThe role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
Biodiversity and ecosystem productivity in a fluctuating environment: The insurance hypothesis
Yachi, S., & Loreau, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1463 · Cited by 3,211 · cited 1×
“Increased microbiome diversity could promote greater stability of the microbiome in the long term, thereby contributing to functional resilience against extreme stress and perturbations [48].”
BackgroundFadrosh, D. W., Ma, B., Gajer, P., Sengamalay, N., Ott, S., Brotman, R. M., & Ravel, J. (2014) · Microbiome · doi:10.1186/2049-2618-2-6 · Cited by 1,698 · cited 1×
“Purified PCR products were sequenced with the Hiseq2500 PE250 platform [35].”
MethodNutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496 · cited 1×
“According to the energy supply ratio of carbohydrates, it can be divided into two modes: very low LCD (<26%), LCD (26~45%) [11].”
BackgroundYoung-Hyman, D., de Groot, M., Hill-Briggs, F., Gonzalez, J. S., Hood, K., & Peyrot, M. (2016) · Diabetes Care · doi:10.2337/dc16-2053 · Cited by 1,072 · cited 1×
“The American Diabetes Association (ADA) [5] and IDF [6] emphasize that: management of mental health is an important aspect of diabetes treatment.”
BackgroundAnxiety, depression, and the microbiome: A role for gut peptides
Lach, G., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0585-0 · Cited by 573 · cited 3×
“GLP-1, produced both in peripheral L-cells of the gastrointestinal tract and in the brain, is an anorexigenic peptide and treatment target for T2DM [26].”
BackgroundDepression in type 2 diabetes mellitus: prevalence, impact, and treatment
Semenkovich, K., Brown, M. E., Svrakic, D. M., & Lustman, P. J. (2015) · Drugs · doi:10.1007/s40265-015-0347-4 · Cited by 447 · cited 2×
“Conversely, a diagnosis of T2DM increases the risk of incident depression and can contribute to a more severe course of depression [2].”
BackgroundGlobal guideline for type 2 diabetes: recommendations for standard, comprehensive, and minimal care
IDF Clinical Guidelines Task Force (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01918.x · Cited by 433
Mediterranean dietary pattern and depression: the PREDIMED randomized trial
Sánchez-Villegas, A., Martínez-González, M. A., Estruch, R., Salas-Salvadó, J., Corella, D., Covas, M. I., Arós, F., Romaguera, D., Gómez-Gracia, E., Lapetra, J., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-208 · Cited by 403 · cited 1×
“Various interventions [18,19], along with two recently published cohort studies [20,21], have found higher nut consumption was associated with lower depression scores.”
BackgroundThe gut microbiome and diet in psychiatry: focus on depression
Dash, S., Clarke, G., Berk, M., & Jacka, F. N. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000117 · Cited by 369
Meng, Y., Bai, H., Wang, S., Li, Z., Wang, Q., & Chen, L. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.006 · Cited by 221 · cited 2×
“However, for T2DM patients, carbohydrate is by far the greatest dietary contributor to blood glucose rise, as expected, dietary carbohydrate restriction reliably reduces glucose profile [9].”
BackgroundSaslow, L. R., Kim, S., Daubenmier, J. J., Moskowitz, J. T., Phinney, S. D., Goldman, V., Murphy, E. J., Cox, R. M., Moran, P., & Hecht, F. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091027 · Cited by 221 · cited 1×
“[43] assessed the effect of a 3-month LCD (lower their carbohydrate consumption and derive their remaining calories from fat) and a LFD on psychological outcomes in obesity/overweight patients with T2DM or pre-diabetes.”
BackgroundCollier, G., & O'Dea, K. (1983) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/37.6.941 · Cited by 219
Dietary fiber and its associations with depression and inflammation
Swann, O. G., Kilpatrick, M., Breslin, M., & Oddy, W. H. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuz072 · Cited by 185
Holscher, H., Taylor, A., Swanson, K., Novotny, J., & Baer, D. (2018) · Nutrients · doi:10.3390/nu10020126 · Cited by 126 · cited 1×
“[56], where they found that almond consumption increased the Roseburia (p < 0.”
BackgroundWeina, H., Yuhu, N., Christian, H., Birong, L., Feiyu, S., & Le, W. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.031 · Cited by 115 · cited 1×
“GLP-1 analog liraglutide has been recently reported to attenuate depressive behaviors via improving hippocampal plasticity in mice [52].”
BackgroundGalletly, C., Moran, L., Noakes, M., Clifton, P., Tomlinson, L., & Norman, R. (2007) · Appetite · doi:10.1016/j.appet.2007.03.222 · Cited by 103 · cited 1×
“Evidence from the literature showed that the mean difference of the changes in the depression score was 2 between the LCD and the LFD group [31].”
BackgroundDhillon, J., Li, Z., & Ortiz, R. M. (2019) · Current Developments in Nutrition · doi:10.1093/cdn/nzz079 · Cited by 69 · cited 1×
“Almonds are a rich source of fiber, unsaturated fats, and polyphenols, all nutrients that can favorably alter the gut microbiome [50] and its consumption increases the number of SCFAs-producing bacteria [23].”
Background
Cited by
The Development and Evaluation of a Literature-Based Dietary Index for Gut Microbiota
Kase, B. E., Liese, A. D., Zhang, J., Murphy, E. A., Zhao, L., & Steck, S. E. (2024) · Nutrients · doi:10.3390/nu16071045 · Cited by 221
Almond By-Products: Valorization for Sustainability and Competitiveness of the Industry
Barral-Martinez, M., Fraga-Corral, M., Garcia-Perez, P., Simal-Gandara, J., & Prieto, M. A. (2021) · Foods · doi:10.3390/foods10081793 · Cited by 107
Detka, J., & Głombik, K. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00274-8 · Cited by 79
Lei, L., Huang, J., Zhang, L., Hong, Y., Hui, S., & Yang, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.935234 · Cited by 35
Aslam, H., Trakman, G., Dissanayake, T., Todd, E., Harrison, P., Alby, C., Jabeen, T., Gamage, E., Travica, N., Marshall, S., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07428-9 · Cited by 30
“Three RCTs assessed low-CHO diets [74, 79, 85].”
Influential
Metadata
- Authors
- Ren, M., Zhang, H., Qi, J., Hu, A., Jiang, Q., Hou, Y., Feng, Q., Ojo, O., & Wang, X.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-10-03
- Volume
- 12
- Issue
- 10
- Pages
- 3036
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W3091728673
- Cited by
- 139
- References
- 20
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.